3-98133390-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001005338.2(OR5H1):c.693T>A(p.Asp231Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000429 in 1,613,160 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005338.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5H1 | NM_001005338.2 | c.693T>A | p.Asp231Glu | missense_variant | 2/2 | ENST00000641874.1 | NP_001005338.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5H1 | ENST00000641874.1 | c.693T>A | p.Asp231Glu | missense_variant | 2/2 | NM_001005338.2 | ENSP00000492953.1 | |||
ENSG00000249225 | ENST00000508964.1 | n.94+14651A>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 151982Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000395 AC: 99AN: 250902Hom.: 1 AF XY: 0.000450 AC XY: 61AN XY: 135630
GnomAD4 exome AF: 0.000435 AC: 635AN: 1461060Hom.: 3 Cov.: 32 AF XY: 0.000436 AC XY: 317AN XY: 726860
GnomAD4 genome AF: 0.000375 AC: 57AN: 152100Hom.: 1 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.693T>A (p.D231E) alteration is located in exon 1 (coding exon 1) of the OR5H1 gene. This alteration results from a T to A substitution at nucleotide position 693, causing the aspartic acid (D) at amino acid position 231 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at